Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leadership & People

Set Alert for Leadership & People

Executives On The Move: Changes At Acceleron, Faron Pharmaceuticals And More

C-suite changes at Relief Therapeutics and promotions at Black Diamond Therapeutics are among recent executive changes in the industry. Meanwhile, new directors were appointed at Adagio Therapeutics, OKYO Pharma and Tenaya Therapeutics, among others.

Executive Changes Leadership

India’s 'Thousand Talents' Moment And Models To Shift Gears In R&D

Industry leaders including Sanofi's ex-CEO and the chiefs of Sun, Lupin, Glenmark, Dr Reddy’s and Cipla discuss how India could leapfrog its pharma R&D efforts. Could the South Korea model or a hybrid approach including bringing back top talent bolster the country’s efforts to emerge as a global innovation hot spot?

India Research & Development

No Way To Go But Grow: J&J Outlines Plans To Become A $60bn Pharma In 2025

Management outlined its growth strategy to investors, highlighting plans to file 14 novel drugs with more than $1bn in peak sales by 2025.

Business Strategies Research & Development

Janssen's Lebowitz On J&J's Oncology Expansion Plans Outside Of Hematology

Janssen global oncology therapeutic area head Peter Lebowitz talked to Scrip about the company's next big ambitions in lung, bladder and prostate cancer.

Cancer Launches

Executives On The Move: Changes At Diurnal Group, Appili Therapeutics And More

C-suite changes at Appili Therapeutics and promotions at Collmune are among recent executive changes in the industry. Meanwhile, new directors were appointed at Diurnal Group, Artios Pharma and Verastem, among others.

Executive Changes Leadership

The Architect Of Biogen's Controversial Alzheimer's Strategy, Al Sandrock, To Retire

Despite 23 years at Biogen assisting in the development of several drugs, Sandrock's legacy will be tied to Alzheimer’s drug Aduhelm.

Leadership Companies

Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite Lightly

The cardiologist seeking another term as FDA commissioner has been working in the pharma industry since leaving the post, but Senators have tended not to  question nominee's work history extensively during previous confirmation hearings.

FDA Leadership

Aurobindo To Formalize Succession Plan In Dec As MD Readies Exit

Aurobindo will formalize a succession plan in early December as managing director N Govindarajan, who has spent over a decade at the company, is set to move on. Meanwhile, though a settlement has been reached for generic Revlimid launch plans, development of a COVID-19 vaccine with partner Vaxxinity has hit a major roadblock

Commercial Leadership

Executives On The Move: Changes At GT Biopharma, Caribou Bioscience And More

C-suite changes at Acorda Therapeutics and promotions at GT Biopharma are among recent executive changes in the industry. Meanwhile, new directors were appointed at Caribou Bioscience, Defence Therapeutics and Beam Therapeutics, among others.

BioPharmaceutical Executive Changes

Tsai Trumpets Productivity of Novartis Pipeline

As the Swiss major took a deep dive on its projects for diseases ranging from pancreatic cancer to osteoarthritis and kidney disease, development head John Tsai spoke about how the firm's digital capabilities are helping those programs advance quicker.

Innovation Strategy

Executives On The Move: Changes At Bioventus, Factor Therapeutics And More

New leaders in investor relations at Johnson & Johnson and promotions at Vivanza Biosciences are among recent executive changes in the industry. Meanwhile, new directors were appointed at Bioventus and AC Immune, among others.

Executive Changes Leadership

Sanofi Accelerates Its ‘Carbon Neutral’ Pledge Ahead Of Climate Summit

The France-headquartered company has brought forward its carbon neutral goal, making it one of the sector’s most proactive companies.

Companies Business Strategies
See All
UsernamePublicRestriction

Register